{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T06:59:00Z","timestamp":1776841140589,"version":"3.51.2"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,20]]},"abstract":"<jats:p>\n                    Totally implantable venous access devices (TIVADs) are widely used in breast cancer patients receiving chemotherapy; however, catheter-related thrombosis can occur and may be asymptomatic. This study aimed to examine the prevalence and associated risk factors of TIVAD-related venous thrombosis in breast cancer patients undergoing chemotherapy. We conducted a retrospective analysis of 143 consecutive breast cancer patients who received TIVAD implantation at our hospital from March 2022 to February 2023. Routine color Doppler ultrasonography of catheter-associated veins was conducted following the conclusion of all chemotherapy cycles and prior to the removal of the TIVAD. Patients were classified into thrombosis and non-thrombosis cohorts. Variables relating to patients, treatments, and catheters were compared among groups. TIVAD-related venous thrombosis was detected in 37 of 143 patients (25.87%); all cases were asymptomatic and identified by routine ultrasound screening prior to TIVAD removal. The median TIVAD retention time was 148 days. A significant difference in TIVAD material was observed between groups (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). No significant differences were found in age, body weight, tumor\u2013node\u2013metastasis (TNM) stage, puncture site, timing of chemotherapy, chemotherapy regimen category, catheter tip position, or TIVAD retention period (all\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&gt;\u2005.05). Asymptomatic TIVAD-associated venous thrombosis is prevalent among breast cancer patients undergoing chemotherapy. TIVAD material may be linked to thrombosis risk, although the duration of TIVAD retention was not substantially correlated with thrombosis in this population.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000048051","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:01:03Z","timestamp":1774036863000},"page":"e48051","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors for TIVAD-related venous thrombosis in Chinese breast cancer patients undergoing chemotherapy: A single-center retrospective study"],"prefix":"10.1097","volume":"105","author":[{"given":"Yin","family":"Li","sequence":"first","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuntao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6333-6634","authenticated-orcid":false,"given":"Xiangwang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260422","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20260422","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","article-title":"Breast cancer.","volume":"397","author":"Loibl","year":"2021","journal-title":"Lancet"},{"key":"R3-20260422","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments.","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"R4-20260422","first-page":"355","article-title":"Evolving standards of care and new challenges in the management of HER2-positive breast cancer.","volume":"70","author":"Choong","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R5-20260422","doi-asserted-by":"crossref","first-page":"1519728","DOI":"10.3389\/fonc.2024.1519728","article-title":"Clinical applications and research progress of totally implantable venous access ports: a literature review.","volume":"14","author":"Huang","year":"2024","journal-title":"Front Oncol"},{"key":"R6-20260422","doi-asserted-by":"crossref","first-page":"20220894","DOI":"10.1259\/bjr.20220894","article-title":"Central venous catheters: which, when and how.","volume":"96","author":"Kehagias","year":"2023","journal-title":"Br J Radiol"},{"key":"R7-20260422","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/j.tvir.2011.05.007","article-title":"Principles of subcutaneous port placement.","volume":"14","author":"Gonda","year":"2011","journal-title":"Tech Vasc Interv Radiol"},{"key":"R8-20260422","doi-asserted-by":"crossref","first-page":"e949000","DOI":"10.12659\/MSM.949000","article-title":"Implantable ports vs peripherally inserted central catheters in breast cancer chemotherapy: a comprehensive meta-analysis.","volume":"31","author":"Chen","year":"2025","journal-title":"Med Sci Monit"},{"key":"R9-20260422","first-page":"3531","article-title":"Availability of totally implantable venous access devices in cancer patients is high in the long term: a seven-year follow-up study.","volume":"29","author":"Tumay","year":"2021","journal-title":"Support Care Cancer"},{"key":"R10-20260422","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.amjmed.2014.01.001","article-title":"PICC-associated bloodstream infections: prevalence, patterns, and predictors.","volume":"127","author":"Chopra","year":"2014","journal-title":"Am J Med"},{"key":"R11-20260422","first-page":"e298","article-title":"Optimizing vascular access for patients receiving intravenous systemic therapy for early-stage breast cancer-a survey of oncology nurses and physicians.","volume":"25","author":"LeVasseur","year":"2018","journal-title":"Curr Oncol (Toronto, Ont.)"},{"key":"R12-20260422","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.7150\/jca.103631","article-title":"Implantable port catheters versus peripherally inserted central catheters for cancer patients requiring chemotherapy: an RCT-based meta-analysis.","volume":"16","author":"Qiu","year":"2025","journal-title":"J Cancer"},{"key":"R13-20260422","doi-asserted-by":"crossref","first-page":"11909","DOI":"10.2147\/CMAR.S282370","article-title":"The influence of venous characteristics on peripherally inserted central catheter-related symptomatic venous thrombosis in cancer patients.","volume":"12","author":"Wang","year":"2020","journal-title":"Cancer Manag Res"},{"key":"R14-20260422","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.thromres.2022.02.024","article-title":"Risk of VTE associated with PORTs and PICCs in cancer patients: a systematic review and meta-analysis.","volume":"213","author":"Wang","year":"2022","journal-title":"Thromb Res"},{"key":"R15-20260422","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/ATVBAHA.120.314378","article-title":"Cancer therapy-associated thrombosis.","volume":"41","author":"Grover","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R16-20260422","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1182\/blood-2018-03-837153","article-title":"Cancer-associated thrombosis in patients with implanted ports: a prospective multicenter French cohort study (ONCOCIP).","volume":"132","author":"Decousus","year":"2018","journal-title":"Blood"},{"key":"R17-20260422","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jtha.2023.11.017","article-title":"Management of catheter-related upper extremity deep vein thrombosis in patients with cancer: a systematic review and meta-analysis.","volume":"22","author":"Wang","year":"2024","journal-title":"J Thromb Haemost"},{"key":"R18-20260422","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1182\/blood-2015-01-625582","article-title":"When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data.","volume":"127","author":"Walker","year":"2016","journal-title":"Blood"},{"key":"R19-20260422","first-page":"1213","article-title":"Low-dose aspirin for the prevention of venous thromboembolism in breast cancer patients treated with infusional chemotherapy after insertion of central vein catheter.","volume":"15","author":"Curigliano","year":"2007","journal-title":"Support Care Cancer"},{"key":"R20-20260422","first-page":"17090","article-title":"Real-life application of the European Society for Medical Oncology guidelines for the prevention and treatment of cancer-associated thrombosis: challenges and perspectives.","volume":"135","author":"Gerotziafas","year":"2025","journal-title":"Pol Arch Intern Med"},{"key":"R21-20260422","doi-asserted-by":"crossref","first-page":"8379","DOI":"10.2147\/CMAR.S212375","article-title":"Risk factors of catheter-related thrombosis in early-stage breast cancer patients: a single-center retrospective study.","volume":"11","author":"Tan","year":"2019","journal-title":"Cancer Manag Res"},{"key":"R22-20260422","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/jjco\/hyae055","article-title":"Incidence and risk factors of PICC-related thrombosis in breast cancer: a meta-analysis.","volume":"54","author":"Meng","year":"2024","journal-title":"Jpn J Clin Oncol"},{"key":"R23-20260422","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.23.00294","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update.","volume":"41","author":"Key","year":"2023","journal-title":"J Clin Oncol"},{"key":"R24-20260422","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1111\/jth.15487","article-title":"Venous thromboembolism associated with central venous catheters in patients with cancer: from pathophysiology to thromboprophylaxis, areas for future studies.","volume":"19","author":"Debourdeau","year":"2021","journal-title":"J Thromb Haemost"},{"key":"R25-20260422","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/NAN.0000000000000582","article-title":"Incidence and risk of catheter-related thrombosis in breast cancer patients with implanted ports.","volume":"48","author":"Luo","year":"2025","journal-title":"J Infusion Nurs"},{"key":"R26-20260422","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.annonc.2022.12.014","article-title":"Venous thromboembolism in cancer patients: ESMO clinical practice guideline.","volume":"34","author":"Falanga","year":"2023","journal-title":"Ann Oncol"},{"key":"R27-20260422","doi-asserted-by":"crossref","first-page":"1679363","DOI":"10.3389\/fonc.2025.1679363","article-title":"Safety of totally implantable venous access devices and peripherally inserted central catheters in hematological malignancies patients: a meta-analysis.","volume":"15","author":"Gu","year":"2025","journal-title":"Front Oncol"},{"key":"R28-20260422","doi-asserted-by":"crossref","first-page":"109030","DOI":"10.1016\/j.thromres.2024.05.003","article-title":"Risk assessment models for PICC-related venous thrombosis in adult patients with cancer: a network meta-analysis.","volume":"239","author":"Hu","year":"2024","journal-title":"Thromb Res"},{"key":"R29-20260422","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.puhe.2022.01.018","article-title":"Risk factors associated with catheter-related venous thrombosis: a meta-analysis.","volume":"205","author":"Liu","year":"2022","journal-title":"Public Health"},{"key":"R30-20260422","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1097\/CCM.0000000000004764","article-title":"The practice and complications of midline catheters: a systematic review.","volume":"49","author":"Tripathi","year":"2021","journal-title":"Crit Care Med"},{"key":"R31-20260422","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","article-title":"2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19.","volume":"23","author":"Farge","year":"2022","journal-title":"Lancet Oncol"},{"key":"R32-20260422","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.3390\/cancers16132308","article-title":"Exploring extravasation in cancer patients.","volume":"16","author":"Pham","year":"2024","journal-title":"Cancers"},{"key":"R33-20260422","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11239-015-1175-9","article-title":"A systematic review of patient-related risk factors for catheter-related thrombosis.","volume":"40","author":"Leung","year":"2015","journal-title":"J Thromb Thrombolysis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T06:01:02Z","timestamp":1776837662000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048051","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"2025-11-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}